Oculis Holding AG
Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.
Key statistics
Against its peers
Compare in full ›| OCS | OCGN | OVID | YDES | OCUL | EYPT | |
|---|---|---|---|---|---|---|
| Market cap | 485.31M | 321.21M | 470.67M | 448.36M | 1.66B | 278.35M |
| P/E (TTM) | — | — | — | — | — | — |
| Forward P/E | -4.1 | -3.7 | -6.4 | — | -5.1 | -1.2 |
| Price/book | 1.9 | -19.3 | 2.1 | 1.4 | 3.2 | 1.7 |
| Dividend yield | — | — | — | — | — | — |
| 1-year change | −60.29% | −40.25% | +55.70% | −63.54% | −36.37% | −74.51% |
| Today | −5.52% | −0.87% | −2.03% | −5.94% | +0.27% | −2.35% |
The closest companies by business and industry (Biotechnology). Prices may be delayed up to 15 min.
Latest news
All OCS news ›Oculis Publishes Notifications of Transactions by Persons Discharging Managerial Responsibilities
The Manila Times Oculis Publishes Notifications of Transactions by Persons Discharging Managerial Responsibilities ZUG, Switzerland, Oct. 08, 2026 (GLOBE NEWSWIRE) -- The attached notification relates to the vesting and settlement of RSUs…
Vantiva announces departure of CEO Tim O'Loughlin
Telecompaper Vantiva announces departure of CEO Tim O'Loughlin Vantiva has announced the departure of group CEO Tim O'Loughlin. Citing personal reasons, O'Loughlin is stepping down immediately and will no longer serve as a director,…
Oculis (NASDAQ:OCS) Sets New 52-Week Low – What’s Next?
Posted by Michael Walen on Oct 10th, 2026 Shares of Oculis Holding AG (NASDAQ:OCS – Get Free Report) hit a new 52-week low during mid-day trading on Friday. The company traded as low as $8.30 and last traded at $8.34, with a volume of…
Oculis to Present Licaminlimab Data at AAO 2026 Meeting
Jon Napitupulu is Director of Media Relations at The Clinical Trial Vanguard. Jon, a computer data scientist, focuses on the latest clinical trial industry news and trends. Oculis to Present Licaminlimab Data at AAO 2026 Meeting Oculis’s…
Oculi and its quest to see the world
By AMELIA JOSEPH | October 7, 2026 VINICIUSMC / PUBLIC DOMAIN In an interview with The News-Letter, Charbel Rizk, a former professor of Electrical and Computer Engineering at Hopkins, shared details about his startup Oculi. Rizk, who hails…
Onterris director Janet Risi Field resigns
Janet Risi Field cited personal reasons, and the company said her departure did not stem from a disagreement over its operations, policies or practices. Onterris, Inc. (ONT) announced that director Janet Risi Field resigned from its Board…
Oculis to Highlight Licaminlimab at Eyecelerator @ AAO 2026 and Partner with Neuro-Ophthalmology Subspecialty Day
October 07, 2026 02:00 ET | Source: Oculis Holding AG Oculis Holding AG At Eyecelerator @ AAO 2026, Dr. Sherif will present Licaminlimab, a novel topical anti-TNFα candidate being developed with a genotype-based precision medicine approach…
Oculis to Present Licaminlimab Precision Medicine Data at AAO 2026 Ahead of Year-End PREDICT-1 Readout
Oculis announces progress on Licaminlimab trial for dry eye disease, with a presentation scheduled at AAO 2026. Licaminlimab is a novel anti-TNFα eye drop candidate aimed at treating TNFR1-mediated dry eye disease with a precision medicine…
Ocorian appoints Global Head of Innovation
channeleye.media Ocorian has appointed Ryan McGrath to the new role of Global Head of Innovation, based in New York City Ryan (pictured) will be working across Ocorian to identify high-value opportunities driven by client-demand, rapidly…
Ocugen Appoints Industry Executive Jolanda Crombach General Manager of European Affiliate
The Manila Times Ocugen Appoints Industry Executive Jolanda Crombach General Manager of European Affiliate - European Affiliate, based in Amsterdam, to support upcoming marketing authorization submissions, OCU410 Phase 3 development…
From articles in the 4Search news index.
In the news
Mentioned with
People in the coverage
Most coverage from
-
manilatimes.net4
-
globenewswire.com2
-
nasdaq.com2
-
stocktitan.net2
-
channeleye.media1
Finance and business coverage in the 4Search news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 16 articles, not a forecast.